USA - engelska - NLM (National Library of Medicine)

hikma pharmaceuticals usa inc. - levofloxacin (unii: 6gnt3y5lmf) (levofloxacin anhydrous - unii:rix4e89y14) - levofloxacin anhydrous 250 mg in 50 ml - levofloxacin injection is indicated for the treatment of adults (≥ 18 years of age) with mild, moderate, and severe infections caused by susceptible isolates of the designated microorganisms in the conditions listed in this section. levofloxacin injection is indicated when intravenous administration offers a route of administration advantageous to the patient (e.g., patient cannot tolerate an oral dosage form). levofloxacin is indicated for the treatment of nosocomial pneumonia due to methicillin-susceptible staphylococcus aureus , pseudomonas aeruginosa , serratia marcescens , escherichia coli , klebsiella pneumoniae , haemophilus influenzae , or streptococcus pneumoniae . adjunctive therapy should be used as clinically indicated. where pseudomonas aeruginosa is a documented or presumptive pathogen, combination therapy with an anti-pseudomonal β-lactam is recommended [see clinical studies (14.1) ]. levofloxacin is indicated for the treatment of community-acquired pneumonia due to methicillin-susceptible sta

USA - engelska - NLM (National Library of Medicine)

west-ward pharmaceuticals corp. - clarithromycin (unii: h1250jik0a) (clarithromycin - unii:h1250jik0a) - clarithromycin 250 mg - clarithromycin is indicated in adults for the treatment of mild to moderate infections caused by susceptible isolates due to haemophilus influenzae, haemophilus parainfluenzae, moraxella catarrhalis, or streptococcus pneumoniae [see indications and usage (1.9) ]. clarithromycin is indicated for the treatment of mild to moderate infections caused by susceptible isolates due to haemophilus influenzae, moraxella catarrhalis, or streptococcus pneumoniae [see indications and usage (1.9) ]. clarithromycin is indicated [see indications and usage (1.9) ] for the treatment of mild to moderate infections caused by susceptible isolates due to: clarithromycin is indicated for the treatment of mild to moderate infections caused by susceptible isolates due to streptococcus pyogenes as an alternative in individuals who cannot use first line therapy. clarithromycin is indicated for the treatment of mild to moderate infections caused by susceptible isolates due to staphylococcus aureus, or streptococcus pyogenes . clari

USA - engelska - NLM (National Library of Medicine)

pd-rx pharmaceuticals, inc. - moxifloxacin hydrochloride (unii: c53598599t) (moxifloxacin - unii:u188xyd42p) - moxifloxacin 400 mg - moxifloxacin hydrochloride is indicated in adult patients for the treatment of community acquired pneumonia caused by susceptible isolates of streptococcus pneumoniae (including multi-drug resistant streptococcus pneumoniae [mdrsp]) ,   haemophilus influenzae, moraxella catarrhalis, methicillin-susceptible staphylococcus aureus, klebsiella pneumoniae, mycoplasma pneumoniae, or chlamydophila pneumoniae [see clinical studies ( 14.3 )] . mdrsp isolates are isolates resistant to two or more of the following antibacterial drugs: penicillin (minimum inhibitory concentrations [mic] ≥ 2 mcg/ml), 2nd generation cephalosporins (for example, cefuroxime), macrolides, tetracyclines, and trimethoprim/sulfamethoxazole. moxifloxacin hydrochloride is indicated in adult patients for the treatment of uncomplicated skin and skin structure infections caused by susceptible isolates of methicillin-susceptible staphylococcus aureus or streptococcus pyogenes [see clinical studies ( 14.4 )]. moxifloxacin hydrochloride is indica

USA - engelska - NLM (National Library of Medicine)

sanum kehlbeck gmbh & co. kg - streptococcus pneumoniae immunoserum rabbit (unii: iwj46h2h5c) (streptococcus pneumoniae immunoserum rabbit - unii:iwj46h2h5c), staphylococcus aureus immunoserum rabbit (unii: q1g8tgq05j) (staphylococcus aureus immunoserum rabbit - unii:q1g8tgq05j) - streptococcus pneumoniae immunoserum rabbit 9 [hp_x] in 10 ml - homeopathic medicine 0.34 fl oz (10 ml) for minor focal oral infections.

USA - engelska - NLM (National Library of Medicine)

sanum kehlbeck gmbh & co. kg - klebsiella pneumoniae (unii: 09pa36ct5r) (klebsiella pneumoniae - unii:09pa36ct5r) - klebsiella pneumoniae 6 [hp_x] in 1 ml - oral homeopathic medicine 50 doses, each 1 ml (.03 fl oz) for temporary relief of bronchial symptoms.

USA - engelska - NLM (National Library of Medicine)

sanum kehlbeck gmbh & co. kg - klebsiella pneumoniae (unii: 09pa36ct5r) (klebsiella pneumoniae - unii:09pa36ct5r) - klebsiella pneumoniae 6 [hp_x] in 10 ml - for temporary relief of bronchial symptoms.

USA - engelska - NLM (National Library of Medicine)

sanum kehlbeck gmbh & co. kg - streptococcus pneumoniae immunoserum rabbit (unii: iwj46h2h5c) (streptococcus pneumoniae immunoserum rabbit - unii:iwj46h2h5c), staphylococcus aureus immunoserum rabbit (unii: q1g8tgq05j) (staphylococcus aureus immunoserum rabbit - unii:q1g8tgq05j) - streptococcus pneumoniae immunoserum rabbit 9 [hp_x] in 10 ml - homeopathic medicine 0.34 fl oz (10 ml) asthma, hay fever and other allergies.

USA - engelska - NLM (National Library of Medicine)

hikma pharmaceuticals usa inc. - cefaclor (unii: 69k7k19h4l) (cefaclor anhydrous - unii:3z6fs3ik0k) - cefaclor anhydrous 250 mg - cefaclor is indicated in the treatment of the following infections when caused by susceptible strains of the designated microorganisms: otitis media caused by streptococcus pneumoniae, haemophilus influenzae , staphylococci, and streptococcus pyogenes lower respiratory tract infections , including pneumonia caused by streptococcus pneumoniae, haemophilus influenzae, and streptococcus pyogenes pharyngitis and tonsillitis , caused by streptococcus pyogenes note : penicillin is the usual drug of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. cefaclor is generally effective in the eradication of streptococci from the nasopharynx; however, substantial data establishing the efficacy of cefaclor in the subsequent prevention of rheumatic fever are not available at present. urinary tract infections , including pyelonephritis and cystitis, caused by escherichia coli, proteus mirabilis, klebsiella spp., and coagulase-negative staphylococci skin and ski

USA - engelska - NLM (National Library of Medicine)

deseret biologicals, inc. - mycoplasma pneumoniae (unii: jqe470fad0) (mycoplasma pneumoniae - unii:jqe470fad0) - mycoplasma pneumoniae 15 [hp_x] in 1 ml - for temporary relief of symptoms related to mycoplasma infection including headache, muscle and joint pain and soreness, and nausea.** **these statements are based upon traditional homeopathic principles. they have not been reviewed by the food and drug administration. for temporary relief of symptoms related to mycoplasma infection including headache, muscle and joint pain and soreness, and nausea.** **these statements are based upon traditional homeopathic principles. they have not been reviewed by the food and drug administration.

USA - engelska - NLM (National Library of Medicine)

deseret biologicals, inc. - mycoplasma pneumoniae (unii: jqe470fad0) (mycoplasma pneumoniae - unii:jqe470fad0) - mycoplasma pneumoniae 15 [hp_x] in 1 ml - for temporary relief of symptoms related to mycoplasma infection including headache, muscle and joint pain and soreness, nausea, lymph node pain, cognitive problems, depression, and breathing problems.** **these statements are based upon traditional homeopathic practice. they have not been reviewed by the food and drug administration. for temporary relief of symptoms related to mycoplasma infection including headache, muscle and joint pain and soreness, nausea, lymph node pain, cognitive problems, depression, and breathing problems.** **these statements are based upon traditional homeopathic practice. they have not been reviewed by the food and drug administration.